Macular Corneal Dystrophy: An Updated Review.

Macular Corneal Dystrophy: An Updated Review.
Curr Eye Res. 2020 Nov 10;:
Authors: Singh S, Das S, Kannabiran C, Jakati S, Chaurasia S
Abstract
Macular Corneal Dystrophy is an autosomal recessive form of corneal dystrophy due to a mutation in CHST6 gene, which results in abnormal proteoglycan synthesis. There is accumulation of abnormal glycosaminoglycans in the corneal stroma and endothelium. The deposition results in progressive loss of corneal transparency and visual acuity. The histopathology shows characteristic alcian blue positive deposits. Management in the cases with visual loss requires keratoplasty either full thickness or lamellar. The decision about the ideal type of keratoplasty depends on age and pre-operative clinical features. Although prognosis after keratoplasty is good, recurrences can occur. Future research should be targeted towards gene therapy in this condition.
PMID: 33171054 [PubMed - as supplied by publisher]

Source: Current Eye Research - November 10, 2020 Category: Opthalmology Authors: Singh S, Das S, Kannabiran C, Jakati S, Chaurasia S Tags: Curr Eye Res Source Type: research